Streetbeat News

Earnings

JNJ

Johnson & Johnson has updated its fiscal year 2024 operational sales forecast to $88.7B-$89.1B, an increase from its previous guidance of $88.2B–$89.0B, surpassing the consensus estimate of $88.43B.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:28 am

JNJ

Johnson & Johnson has updated its 2024 adjusted EPS forecast to $10.57–$10.72, aligning closely with the consensus estimate of $10.66 and slightly adjusting its prior guidance of $10.55–$10.75. The company also provided an adjusted operational EPS range of $10.60–$10.75.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:26 am

UNH

UnitedHealth shares are trading higher after the company reported better-than-expected earnings for the first quarter.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:23 am

JNJ

Johnson & Johnson (JNJ) reported Q1 2024 adjusted EPS of $2.71, surpassing the $2.64 estimate, marking a 12.45% year-over-year increase. However, their sales of $21.383B slightly missed the $21.398B estimate, though still representing a 2.34% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:22 am

UNH

UnitedHealth has reaffirmed its full-year 2024 adjusted EPS forecast to be in the range of $27.50-$28.00, aligning closely with the consensus estimate of $27.53. This outlook excludes direct response costs and the impact of the Brazil sale but includes an estimated $0.30 to $0.40 per share impact from business disruptions related to Change Healthcare services.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:06 am

UNH

UnitedHealth has revised its full-year 2024 GAAP net earnings forecast to $17.60-$18.20 per share, accounting for the sale of its Brazil operations and the estimated direct costs associated with a recent cyberattack.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:05 am

CBSH

Commerce Bancshares (NASDAQ:CBSH) reported Q1 earnings of $0.86 per share, surpassing the $0.81 estimate, a 4.44% decrease from last year's $0.90. Sales reached $397.85M, exceeding the $390.36M estimate, marking a 2.21% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 10:04 am

ERIC

FIVG

IDGT

Ericsson (NASDAQ:ERIC) shares rose in premarket trading after reporting Q1 FY24 results, with a 15% Y/Y sales decline but improved margins and EPS beating consensus. The company anticipates further RAN market decline through the year but expects sales stabilization in H2 FY24. Exposure to ERIC can be gained through IShares U.S. Digital Infrastructure And Real Estate ETF (NYSE:IDGT) and Defiance Next Gen Connectivity ETF (NYSE:FIVG).

Portfolio Pulse from Lekha Gupta

April 16, 2024 | 10:00 am

UNH

UnitedHealth Group (UNH) reported Q1 2024 adjusted EPS of $6.91, surpassing the $6.62 estimate, and sales of $99.796B, exceeding the $99.290B estimate. This represents a 10.38% increase in EPS and an 8.56% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 9:56 am

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares are facing a potential third consecutive session decline, premarket trading shows a 1.98% drop to $161.48. This downturn is attributed to concerns over significant layoffs, including high-profile executives, which erased about $30 billion from its market cap. The upcoming Q1 earnings report and rumors of halting a sub-$30,000 electric car project have also contributed to negative sentiment. Additionally, weak insurance registration data in China could further impact Tesla's stock.

Portfolio Pulse from Shanthi Rexaline

April 16, 2024 | 9:23 am